Medical device specialist DexCom (NASDAQ: DXCM) has substantially underperformed the market over the trailing-12-month period. DexCom develops continuous glucose monitoring (CGM) devices that help ...

在2024年，该公司在美国发布了最新版本的G系列——G7。DexCom在7月底发布第二财季业绩后，股价大幅下跌，但从长期表现来看，这一下跌并不算异常。考虑DexCom从2005年到2018年的表现可以看出。DexCom的股价曾多次大幅下跌，但其中一个 ...

After hours: January 31 at 7:12:31 PM EST ...

The FDA has cleared Dexcom’s Stelo as the first continuous glucose monitoring (CGM) device that does not need a prescription, which can be used by diabetics on oral medications, as well as non ...

Skip More from 5 Live... What Elis James and John Robins got up to in 2024 It’s time to recap on some of Elis James and John Robins' best moments of 2024. Six things we didn't know about being a ...

News and insight from the business world.